These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 32473637

  • 1. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
    Fu K, Zhang L, Liu R, Shi Q, Li X, Wang M.
    World J Surg Oncol; 2020 May 30; 18(1):115. PubMed ID: 32473637
    [Abstract] [Full Text] [Related]

  • 2. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, Liu J, Wei X.
    Mol Cell Biochem; 2021 Nov 30; 476(11):4031-4044. PubMed ID: 34244973
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R, Wang H, Yang B.
    Bioengineered; 2021 Dec 30; 12(2):10596-10607. PubMed ID: 34895048
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ, Wang Y, Wang YY.
    J Cell Physiol; 2019 Jun 30; 234(6):9577-9591. PubMed ID: 30480801
    [Abstract] [Full Text] [Related]

  • 5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Jun 30; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 6. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH, Wang HB.
    J Cell Physiol; 2019 Aug 30; 234(10):18587-18601. PubMed ID: 30953349
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov 30; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

  • 8. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P, Jiao Y, Hao M, Tang X.
    J Cell Biochem; 2018 Jul 30; 119(7):5243-5252. PubMed ID: 29236322
    [Abstract] [Full Text] [Related]

  • 9. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C, Zheng X, Li W, Bai F, Lyu J, Meng QH.
    BMC Cancer; 2018 Jan 09; 18(1):61. PubMed ID: 29316891
    [Abstract] [Full Text] [Related]

  • 10. MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2.
    Zhang L, Liu F, Fu Y, Chen X, Zhang D.
    Life Sci; 2020 Aug 01; 254():117558. PubMed ID: 32198053
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.
    Han N, Li H, Wang H.
    Cell Adh Migr; 2020 Dec 01; 14(1):227-241. PubMed ID: 32990143
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L, Chen Y, Liu J, Nie K, Xiao Y, Yu H.
    Cancer Biomark; 2020 Dec 01; 29(3):347-357. PubMed ID: 32716350
    [Abstract] [Full Text] [Related]

  • 13. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W, Xie T.
    Reprod Sci; 2020 Jan 01; 27(1):132-144. PubMed ID: 32046405
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA CCAT2 acts as an oncogene in osteosarcoma through regulation of miR-200b/VEGF.
    Liu J, Kong D, Sun D, Li J.
    Artif Cells Nanomed Biotechnol; 2019 Dec 01; 47(1):2994-3003. PubMed ID: 31322006
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM, Li XJ, Yang HL, Zhang YB, Li JC.
    Eur Rev Med Pharmacol Sci; 2019 Jun 01; 23(11):4688-4697. PubMed ID: 31210295
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H, Ding Y, Yang X.
    Biomed Res Int; 2021 Jun 01; 2021():6619730. PubMed ID: 34250088
    [Abstract] [Full Text] [Related]

  • 17. miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway.
    Lu X, Song X, Hao X, Liu X, Zhang X, Yuan N, Ma H, Zhang Z.
    Bioengineered; 2021 Dec 01; 12(1):7079-7092. PubMed ID: 34551673
    [Abstract] [Full Text] [Related]

  • 18. LncRNA SNHG5 promotes cervical cancer progression by regulating the miR-132/SOX4 pathway.
    Zhang L, Wu X, Li Y, Teng X, Zou L, Yu B.
    Autoimmunity; 2021 Mar 01; 54(2):88-96. PubMed ID: 33622094
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway.
    Zhang F, Liu J, Xie BB.
    J Cell Physiol; 2019 Aug 01; 234(10):18626-18638. PubMed ID: 31049956
    [Abstract] [Full Text] [Related]

  • 20. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3.
    Wan X, Guo D, Zhu Q, Qu R.
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep 01; 319(3):G309-G322. PubMed ID: 32463333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.